Role of microglia in senile plaque formation
- PMID: 8532113
- DOI: 10.1016/0197-4580(95)00092-s
Role of microglia in senile plaque formation
Abstract
To assess the role of microglial cells in senile plaque (SP) formation, we examined the density and distribution of microglia in the temporal neocortex of three groups of nondemented individuals, chosen to represent sequential stages of SP formation (no SP, n = 14; diffuse plaques (DP) only, n = 12; both DP and neuritic plaques (NP), n = 14) and patients with Alzheimer's disease (AD, n = 11). The mean density of microglia was significantly greater in the AD group. In nondemented individuals, the presence of NP but not DP was associated with an increased number of microglial cells. Most NP (91%) were focally associated with microglial cells. DP less commonly contained microglia, however, individuals with some NP had microglia within a greater proportion of their DP (47%) than did those with only DP (19%). These findings suggest that: (a) microglia are not involved in the formation of DP; (b) the presence of NP is associated with both an overall increase in microglia and the focal aggregation of cells around NP; (c) microglia may be locally involved in the conversion of DP into NP. This final point represents the most significant aspect of this study, providing the first quantitative evidence to support a specific role for microglia in the formation of NP from DP.
Similar articles
-
Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals.Neurodegeneration. 1996 Mar;5(1):13-7. doi: 10.1006/neur.1996.0002. Neurodegeneration. 1996. PMID: 8731377
-
Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.Neurology. 1998 Apr;50(4):986-90. doi: 10.1212/wnl.50.4.986. Neurology. 1998. PMID: 9566383
-
Increased senile plaques without microglia in Alzheimer's disease.Acta Neuropathol. 1991;81(3):242-7. doi: 10.1007/BF00305864. Acta Neuropathol. 1991. PMID: 2058362
-
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain.Neurobiol Aging. 2004 May-Jun;25(5):675-83. doi: 10.1016/j.neurobiolaging.2003.12.026. Neurobiol Aging. 2004. PMID: 15172747 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.Int J Mol Sci. 2021 Mar 25;22(7):3365. doi: 10.3390/ijms22073365. Int J Mol Sci. 2021. PMID: 33805974 Free PMC article. Review.
-
Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.Neurotox Res. 2005 Oct;8(1-2):25-50. doi: 10.1007/BF03033818. Neurotox Res. 2005. PMID: 16260384 Review.
-
Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism.Neurobiol Aging. 2012 Oct;33(10):2247-61. doi: 10.1016/j.neurobiolaging.2011.10.027. Epub 2011 Dec 1. Neurobiol Aging. 2012. PMID: 22133278 Free PMC article.
-
Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.Glia. 2018 Dec;66(12):2700-2718. doi: 10.1002/glia.23522. Epub 2018 Sep 12. Glia. 2018. PMID: 30277607 Free PMC article.
-
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.BMC Neurosci. 2010 Mar 26;11:44. doi: 10.1186/1471-2202-11-44. BMC Neurosci. 2010. PMID: 20346144 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous